NEW YORK, Nov. 2 (GenomeWeb News) - Shares in Third Wave were down 13.2 percent, or $.47, at $3.08 in mid-afternoon trading after the company announced this morning that third-quarter revenue fell by half and net losses grew more than 300 fold.
As GenomeWeb News reported earlier today, Third Wave's blamed its revenue decline on a "reduction in non-recurring research revenue from
Separately today, research firm Caris & Company downgraded the stock to "Below Average" from "Average."